| GDC-0032 基本信息 | |||
|---|---|---|---|
| CAS号 | 1282512-48-4 | 分子式 | C24H28N8O2 |
| 分子量 | 460.53200 | 精确质量 | 460.23400 |
| PSA | N/A | LogP | N/A |
合成路线 共1页 1282513-03-4
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid
→
~79%
1282512-48-4
Taselisib
1282514-63-9
CDC0032中间体
→
1282512-48-4
Taselisib
1282516-65-7
1282516-65-7
→
1282512-48-4
Taselisib
1282516-68-0
9-bromo-2,3-diiodo-5,6-dihydrobenzo[f ]imidazo[1,2-d][1,4]oxazepine
→
1282512-48-4
Taselisib
1282516-67-9
9-bromo-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine
→
1282512-48-4
Taselisib
1282516-66-8
3-bromo-6-(1,3-dihydroimidazol-2-ylidene)cyclohexa-2,4-dien-1-one
→
1282512-48-4
Taselisib
22532-62-3
4-溴-2-羟基苯甲醛
→
1282512-48-4
Taselisib
1282514-64-0
ethyl 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate
→
1282512-48-4
Taselisib
1282514-63-9
CDC0032中间体
+
1282518-81-3
1282518-81-3
→
1282512-48-4
Taselisib